Showing results (51-60 of 533) with videos related to
Sort By:
Pageof 54
Developmental Biology|February 1, 1983
The activation of RNA synthesis by somatic nuclei injected into amphibian oocytesL Wakefield, E Ackerman, J B GurdonCanadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 1, 1992
The air-liquid interface and the pH and PCO2 of alkalinized local anaesthetic solutionsW E Ackerman, T R Ware, M JunejaCurrent Opinion in HIV and AIDS|April 30, 2019
Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1Srivamshi Pittala, Kyle S Morrison, Margaret E AckermanJournal of Athletic Training|April 19, 2022
Knowledge of the Female Athlete Triad and Relative Energy Deficiency in Sport Among Female Cross-Country Athletes and Support StaffMelissa T Lodge, Kathryn E Ackerman, Jessica GarayAmerican Journal of Clinical Pathology|February 1, 1977
Economic impact of a computer-based centralized organization in a clinical laboratoryB Nussbaum, T Minckler, R Roby, et al.Molecular Cancer Therapeutics|July 23, 2008
Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroidsMargaret E Ackerman, David Pawlowski, K Dane WittrupAnnual Review of Medicine|November 15, 2011
Emerging concepts on the role of innate immunity in the prevention and control of HIV infectionMargaret E Ackerman, Anne-Sophie Dugast, Galit AlterCurrent Opinion in HIV and AIDS|February 21, 2015
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-lifeAustin W Boesch, Galit Alter, Margaret E AckermanProtein Science : a Publication of the Protein Society|August 21, 2024
A comparison of antibody-antigen complex sequence-to-structure prediction methods and their systematic biasesKatherine Maia McCoy, Margaret E Ackerman, Gevorg GrigoryanIscience|September 19, 2024
Positive-unlabeled learning to infer protection status and identify correlates in vaccine efficacy field trialsShiwei Xu, Natasha S Kelkar, Margaret E AckermanPageof 54